Business
Photonike Capital S A : Nucleus Life AG approval of Financial Statements 2023 next April, 29th. Net Profit at 596.897 CHF
Photonike Capital S A : Nucleus Life AG approval of Financial Statements 2023 next April, 29th. Net Profit at 596.897
About this update from Photonike Capital Sa
Nucleus Life AG approval of Financial Statements 2023 next April, 29th. Net Profit at 596.897 CHF 18 Apr 2024 18:11 CEST Subscribe Issuer PHOTONIKE CAPITAL Photonike Capital informs that the Board of Directors of Nucleus Life Ag convened the Ordinary Shareholders Assembly for the approval of the 2023 Financial Statements on 29 April 2024. The ultimate version, ratified by the external auditor Grant Thornton, gives a Net Profit of 596,897 CHF of which 523.978 CHF result of the insurance technical accounts. The BoD also approved the BP 2024-2027 relating to the new product catalogue and the new distribution network presented at the FMA. Year 2024 (CHF) 2025 (CHF) 2026 (CHF) 2027 (CHF) New premiums 133,675.000 167.625.000 191.650.000 191,650.000 Portfolio 218.406.484 367.591.936 532.600.830 692.816.350 Net P/L -360.520 433.388 1.255.722 1.975.931 Photonike Capital SA plans to increase the participation in the parent company NHII SCSp by 2025. Source PHOTONIKE CAPITAL Provider Euronext Company Name PHOTONIKE CAPITAL ISIN BE0948608451 Symbol MLPHO Market Euronext Access
View stock analysis, news, and events for Photonike Capital Sa